Major depressive disorder (MD) is a debilitating public mental health problem with severe societal and personal costs attached. Around one in six people will suffer from this complex disorder at some point in their lives, which has shown considerable etiological and clinical heterogeneity. Overall there remain no validated biomarkers in the youth population at large that can aid the detection of at-risk groups for depression in general and for boys and young men in particular. Using repeated measurements of two well-known correlates of MD (self-reported current depressive symptoms and early-morning cortisol), we undertook a population-based investigation to ascertain subtypes of adolescents that represent separate longitudinal phenotypes. Subsequently, we tested for differential risks for MD and other mental illnesses and cognitive differences between subtypes. Through the use of latent class analysis, we revealed a high-risk subtype (17% of the sample) demarcated by both high depressive symptoms and elevated cortisol levels. Membership of this class of individuals was associated with increased levels of impaired autobiographical memory recall in both sexes and the greatest likelihood of experiencing MD in boys only. These previously unidentified findings demonstrate at the population level a class of adolescents with a common physiological biomarker specifically for MD in boys and for a mnemonic vulnerability in both sexes. We suggest that the biobehavioral combination of high depressive symptoms and elevated morning cortisol is particularly hazardous for adolescent boys.adolescence | gender differences M ajor depressive disorder (MD) is a serious mental health problem predicted to be the leading health burden worldwide by 2030 (1, 2). MD increases markedly during adolescence and young adulthood: 25% of lifetime mood disorders appear by 18 y of age and 50% by the age of 30 y (3). MD in childhood or adolescence raises the risk of future episodes in adulthood some fourfold (4), especially in adolescent boys and younger men aged 15-35 y (5, 6). The sex ratio for depression is about equal in childhood, but, by the end of adolescence, females outnumber males by a factor of around two to one (7,8). Whether there are underlying mechanisms associated with the emergence of MD during adolescence that are themselves sex-specific is unknown. If this distinction were so, then biomarkers for MD might themselves be preferentially activated in one sex compared with another.Current diagnostic classifications [e.g., the Diagnostic and Statistical Manual for Mental Disorders (DSM) and the International Classification of Diseases (ICD)] have proved to have low diagnostic validity for investigations on the etiology, prevention, or treatment of MD partly because they ignore heterogeneity (9). Identifying predictive biomarkers (10) has been hampered by this variation because the current taxonomic systems may conflate disorders of similar clinical phenotype that have distinctly different aetiologies (11)(12)(13)(14). One approach to t...